Dilated Cardiomyopathy in Childhood
Overview
Authors
Affiliations
Dilated Cardiomyopathy is an uncommon disease in children but morbidity and mortality in affected patients are high. This review discuses clinical presentation, diagnosis, medical management and prognosis of the condition, with an emphasis on recent advances that have influenced management of these children.
Moisa S, Miron I, Tarca E, Trandafir L, Lupu V, Lupu A Children (Basel). 2022; 9(3).
PMID: 35327707 PMC: 8946943. DOI: 10.3390/children9030335.
Chen F, Chang P, Lin Y, Lin P Nutrients. 2018; 10(11).
PMID: 30405022 PMC: 6266971. DOI: 10.3390/nu10111697.
Teixeira Farinha I, Miranda J J Cardiovasc Dev Dis. 2018; 3(4).
PMID: 29367574 PMC: 5715726. DOI: 10.3390/jcdd3040031.
Proteasome dysfunction in cardiomyopathies.
Gilda J, Gomes A J Physiol. 2017; 595(12):4051-4071.
PMID: 28181243 PMC: 5471412. DOI: 10.1113/JP273607.
Idiopathic dilated cardiomyopathy in children; Natural history and predictors of prognosis.
Saad I Libyan J Med. 2011; 2(3):129-34.
PMID: 21503211 PMC: 3078205. DOI: 10.4176/070501.